Register for an account

X

Enter your name and email address below.

Your email address is used to log in and will not be shared or sold. Read our privacy policy.

X

Website access code

Enter your access code into the form field below.

If you are a Zinio, Nook, Kindle, Apple, or Google Play subscriber, you can enter your website access code to gain subscriber access. Your website access code is located in the upper right corner of the Table of Contents page of your digital edition.

Health

Depressed Mice Just Need a Shot of Gene Therapy in the Brain

80beatsBy Andrew MosemanOctober 21, 2010 8:45 PM
BrainBlack.jpg

Newsletter

Sign up for our email newsletter for the latest science news

According to a new study out in Science Translational Medicine, treating depressed mice with gene therapy in the brain to bolster a protein connected to the neurotransmitter serotonin can make those depressive symptoms dissipate. Here's the gist: The gene in question creates a protein called p11 that help carry serotonin receptors up to the surface of a brain cell where they can receive signals from other brain cells. Poor serotonin signaling may be one of the major drivers behind depression, and a dearth of p11 could worsen the problem, according to study author Michael Kaplitt.

"In the absence of p11, a neuron can produce all the serotonin receptors it needs, but they will not be transported to the cell surface," said Kaplitt. [AFP]

To test this, back in 2006 Nobel winner

Paul Greengard (another coauthor on this study) created mice engineered to lack p11. Indeed, those mice developed the signs of severe depression. This time around, the team took similarly depressed mice and injected a reward center in their brain (the nucleus accumbens

) with a virus that gave them a shot of p11. According to the researchers, the boost turned around the mice's depression symptoms and they began to act like normal mice.

"Psychological disorders, such as depression, are increasingly viewed as brain disorders," says study author Michael Kaplitt of the Weill Cornell Medical College in New York City. "If true, we may be able to help some patients by bringing levels of this protein back to normal." [USA Today]

That said, the main criticisms of Kaplitt's study note that depression is much more complicated than a single gene, protein, or receptor. And is a treatment as invasive as gene therapy on the brain really necessary for treating depression, or even effective against the most serious forms of the illness?

Because the treatment is invasive — requiring brain surgeons to drill into the skull and deliver the therapy to the right spot in the brain — it should only be used by severely afflicted patients that don't respond to other drugs. "But that's really not what the study tested," says [Husseini] Manji, whose commentary on the study was also published in Science Translational Medicine today. The mice in the study might well have responded to Prozac, and it is not clear whether the treatment does treat the severest forms of the disorder. [Nature]

Worries aside, these types of therapies are on the horizon. The scientists involved in this study are also testing similar procedures for Parkinson's disease. Kaplitt is working on a new project to test the p11 treatment in non-human primates, which could pave the way for human trials. Related Content: DISCOVER: Psychologist Says Antidepressants Are Just Fancy Placebos

80beats: Gene Therapy Hope for HIV: Engineered Stem Cells Hold Promise

80beats: Gene Therapy That Bulks up Muscles Raises Doping Concerns

80beats: Scientists See the Foreshadowing of Depression in Brain Anatomy

Image: iStockphoto

2 Free Articles Left

Want it all? Get unlimited access when you subscribe.

Subscribe

Already a subscriber? Register or Log In

Want unlimited access?

Subscribe today and save 70%

Subscribe

Already a subscriber? Register or Log In